Covalent Modification of Synthetic Hydrogels with Bioactive Proteins via Sortase-Mediated Ligation by Cambria, Elena et al.
Covalent Modiﬁcation of Synthetic Hydrogels with Bioactive Proteins
via Sortase-Mediated Ligation
Elena Cambria,†,# Kasper Renggli,†,# Caroline C. Ahrens,‡ Christi D. Cook,†,§ Carsten Kroll,∥,∇
Andrew T. Krueger,∥,○ Barbara Imperiali,∥,⊥ and Linda G. Griﬃth*,†,§
†Department of Biological Engineering, ‡Department of Chemical Engineering, §Center for Gynepathology Research, ∥Department of
Chemistry and ⊥̂Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts United States
*S Supporting Information
ABSTRACT: Synthetic extracellular matrices are widely used
in regenerative medicine and as tools in building in vitro
physiological culture models. Synthetic hydrogels display
advantageous physical properties, but are challenging to
modify with large peptides or proteins. Here, a facile, mild
enzymatic postgrafting approach is presented. Sortase-
mediated ligation was used to conjugate human epidermal growth factor fused to a GGG ligation motif (GGG-EGF) to
poly(ethylene glycol) (PEG) hydrogels containing the sortase LPRTG substrate. The reversibility of the sortase reaction was then
exploited to cleave tethered EGF from the hydrogels for analysis. Analyses of the reaction supernatant and the postligation
hydrogels showed that the amount of tethered EGF increases with increasing LPRTG in the hydrogel or GGG-EGF in the
supernatant. Sortase-tethered EGF was biologically active, as demonstrated by stimulation of DNA synthesis in primary human
hepatocytes and endometrial epithelial cells. The simplicity, speciﬁcity, and reversibility of sortase-mediated ligation and cleavage
reactions make it an attractive approach for modiﬁcation of hydrogels.
1. INTRODUCTION
The need for in vitro physiological models and for clinical
therapies has driven the development of synthetic biomaterials
that recapitulate key features of the extracellular matrix
(ECM).1 Polymer hydrogels are an attractive foundation for
synthetic ECM, as their biophysical and biochemical properties
can be tuned in modular fashion to control cellular phenotype.
Hydrogels built from macromers containing highly ﬂexible,
hydrophilic poly(ethylene glycol) (PEG) have found especially
widespread use due to their biocompatibility, relative inertness
to nonspeciﬁc cell interactions, relative ease of functionalization
with biomolecular motifs, and commercial availability of
reactive PEG macromers of various molecular weights and
branching conﬁgurations.2−5 However, unmodiﬁed PEG hydro-
gels possess limited or no intrinsic biological function and thus
may fail to support desired cell behaviors.
Many strategies have been explored to modify PEG
hydrogels with ECM-derived biological cues such as adhesion
peptides and growth factors,6−9 but facile, site-speciﬁc attach-
ment of large peptides and proteins in a way that retains
bioactivity remains a challenge, particularly if the approaches
are intended to be used in the presence of cells. Photo-
polymerization and conjugation of peptides or proteins through
amine groups10−14 are straightforward, but lack speciﬁcity and
may alter protein function. Conjugation through click
chemistry allows increased intermediate stability and improved
eﬃciency of hydrogel conjugation; however, this approach is
limited by the diﬃculties associated with producing proteins
that incorporate precursors for click chemistry in an
appropriate site-speciﬁc manner.9
Here, we describe the use of sortase-mediated ligation of
epidermal growth factor (EGF) to PEG-based synthetic ECM
hydrogels. Sortases are transpeptidases found in Gram-positive
bacteria, which anchor surface proteins to the bacterial cell wall
in vivo.15 The enzyme sortase A from Staphylococcus aureus
recognizes a speciﬁc LPXTG motif (X = any amino acid except
proline), cleaves the amide bond between the threonine and
the glycine, and covalently attaches an oligoglycine nucleo-
phile.16 Moreover, the formed product maintains the LPXTG
motif, allowing controlled release or cleavage of the tethered
protein through a second sortase-mediated transpeptidase
reaction in the presence of a soluble N-terminal oligoglycine
nucleophile (e.g., triglycine, GGG).
Sortase-mediated ligation has found numerous applications
in puriﬁcation, modiﬁcation and immobilization of pro-
teins.17,18 It has been used to conjugate proteins to diﬀerent
types of surfaces,19−27 liposomes28 and peptides.29,30 Here we
extend sortase-mediated ligation to the modiﬁcation of
synthetic ECM hydrogels. Compared to other enzymatic
approaches,31 sortase-mediated ligation oﬀers the advantage
of enhanced catalytic rate due to the engineering of mutant
sortases,32 enhanced diﬀusion rate due to the relatively small
size of the sortase (23.5 kDa), high yield of recombinant
expression and relatively modest propensity to modify known
mammalian proteins.33
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In this study, we ligated EGF to relatively soft, permeable
PEG hydrogels prefunctionalized with cell adhesion motifs. The
biophysical and cell adhesion properties of hydrogels were
designed to support physiological culture of primary human
epithelial cells. We formed hydrogels by copolymerizing
acrylate-terminated multiarm PEG with a thiol-terminated
LPRTG peptide and thiol-terminated multiarm PEG through
Michael-type addition (Scheme 1) as reported earlier.3 This
cross-linking was carried out in the presence of a cell adhesion
peptide bearing a thiol reactive group to render the resulting
hydrogels adhesive to primary human epithelial cells. An
evolved triple mutant of the sortase A enzyme (P94S/D160N/
K196T) developed by Liu and co-workers32 was used to tether
the previously reported N-terminal Gly3-tagged human
epidermal growth factor (GGG-EGF)30 to the hydrogel
(Scheme 1). Characterization of the system included sortase-
mediated cleavage of the tethered EGF for quantiﬁcation in
solution. To test the bioactivity of the tethered EGF, we
investigated DNA synthesis with EGF-responsive human
cryopreserved hepatocytes and primary human endometrial
Scheme 1. Process Used to Tether GGG-EGF to the Hydrogela
aTop: Hydrogels are formed by Michael-type additions of 8-arm PEG-acrylate stars cross-linked with 4-arm PEG-thiol stars. Adhesion peptides
(SynKRGD) and sortase motif peptides (LPRTG) can also be cross-linked into the hydrogel if they contain a cysteine residue to react with the
acrylate of the 8-arm PEG star. Bottom: (A) Sortase-mediated ligation of GGG-EGF to pre-formed PEG hydrogels containing LPRTG peptide. (B)
Sortase diﬀuses into the hydrogel, cleaves the peptide bond between the threonine and the glycine of the LPRTG peptide, releasing G, then the N-
terminus of GGG-EGF, which has diﬀused into the hydrogel, is ligated to the C-terminus of the LPRT-motif (C). The same sequence of steps can be
used to cleave EGF once it is ligated to the hydrogel, by adding sortase and the simple peptide GGG; GGG will displace tethered EGF, releasing it
into solution.
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epithelial cells. Our results illustrate several features of the
sortase-mediated ligation reaction as implemented for mod-
iﬁcation of synthetic ECM hydrogels, including the ability to
eﬃciently release tethered proteins via a sortase-mediated
reaction with a small soluble oligoglycine substrate, GGG.
2. EXPERIMENTAL SECTION
2.1. Materials. Commercially available chemicals, including
triglycine (GGG), were purchased from Sigma-Aldrich and used
without further puriﬁcation unless otherwise noted. PEG macromers
(10 kDa 8-arm PEG-acrylate and 5 kDa 4-arm PEG-thiol) were
purchased from JenKem. All custom peptides were synthesized by
Boston Open Laboratories, USA, as follows: Ac-CRGLPRTGG-
CONH2 (LPRTG), Ac-CRGLPRTGGK(ε-ﬂuorescein)-CONH2
(LPRTG-fam), PHSRNGGGK(εGGG ERCG-Ac)-GGRGDSPY
(synKRGD) and PHSRNGGGK(εGGGERCG-Ac)-GGRDGSPY
(scrambled synKRDG). Hydrogels were formed in 96-well angio-
genesis plates (0.125 cm2; Ibidi). The recombinant sortaggable GGG-
EGF (human EGF fused to a triglycine sequence at the N-terminus)
and the evolved triple mutant (P94S/D160N/D165A) of the sortase A
enzyme32 were expressed and puriﬁed as previously reported.30
Reagents from the DuoSet EGF ELISA kit (R&D Systems, DY236-05)
were used for EGF detection. Cryopreserved hepatocytes (Human
Plateable Hepatocytes, Induction Qualiﬁed, lot# Hu1663) and
hepatocyte media were purchased from Life Technologies. Human
wild type EGF (hEGF) was obtained from Invitrogen (PHG0313).
2.2. Hydrogel Fabrication and Sortase-Mediated Ligation of
GGG-EGF. Using Michael-type addition as described earlier3 nominal
(preswelling) 5% w/v polymer hydrogels with 1:1 thiol:acrylate ratio
were synthesized by preincubating PEG-acrylate macromers with
LPRTG and adhesion peptides in phosphate buﬀered saline (PBS) at
pH 6.9 for 20 min. Adhesion peptides (synKRGD or scrambled
synKRDG) were added at a nominal concentration of 500 μM and
LPRTG nominal concentrations varied from 0 to 250 μM. PEG-thiol
cross-linking macromers were added and 10 μL hydrogels were formed
within the inner wells of a 96-well angiogenesis plate. After gelation
[around 1 h at room temperature (RT)], hydrogels were covered with
PBS and allowed to swell for 90 min at 4 °C with PBS changes every
30 min. They were further allowed to swell in intermediate buﬀer (50
mM HEPES, 150 mM NaCl, pH 7.9) for 90 min at 4 °C with buﬀer
changes every 30 min. Hydrogels were blocked with 70 μL/well
calcium buﬀer (50 mM HEPES, 150 mM NaCl, 10 mM CaCl2, pH
7.9) containing 0.5% puriﬁed bovine casein for 1 h at RT. Tethering
solution containing 2 or 20 μM GGG-EGF and 15 μM sortase enzyme
in calcium buﬀer was added to the hydrogels (50 μL per well) and the
reaction was allowed to proceed for 1 h at RT with constant agitation
at 30 rpm. Tethering solution without sortase was used to test for
nonspeciﬁc binding of GGG-EGF to hydrogels and calcium buﬀer was
used for control and in soluble EGF conditions. The sortase reaction
was stopped by addition of 5 μL/well of ethylenediaminetetraacetic
acid (EDTA; 300 mM), then supernatants were collected and frozen at
−80 °C for EGF quantiﬁcation, and hydrogels were extensively
washed (3× immediately and every 30 min for 3 h) with 70 μL/well
intermediate buﬀer and soaked overnight at 4 °C.
2.3. Hydrogel Fluorescence Measurements for Quantiﬁca-
tion of Incorporated or Sortase-Cleaved LPRTG. Hydrogels
containing a mix of 96% LPRTG and 4% LPRTG-fam peptides with
varying total nominal peptide concentrations of 0, 20, 50, 100, or 250
μM were cross-linked in 96-well angiogenesis plates as described
above. After 6 × 30 min washes at 4 °C, intermediate buﬀer (50 μL)
was added on top of each hydrogel and ﬂuorescence (λex = 485 nm;
λem = 530 nm) was measured using a microplate reader (SpectraMax
M2e, Molecular Devices). A linear standard curve was established by
measuring the ﬂuorescence of hydrogels containing 0, 20, 50, 100, or
250 μM of total LPRTG peptide (Supporting Information Figure 1).
After incubation for 1 h with either 2 μM or 20 μM GGG-EGF in the
presence of 15 μM sortase the reaction was stopped with 5 μL/well
EDTA (300 mM) and hydrogels were extensively washed (3×
immediately, every 30 min for 3 h and soaked overnight at 4 °C)
before ﬂuorescence reading. In order to correct for photobleaching,
decreased ﬂuorescence of control hydrogels was measured in the
absence of sortase (Supporting Information Figure 2).
2.4. GGG-EGF Detection via Direct ELISA on Hydrogels.
Hydrogels were blocked with Odyssey Blocking Buﬀer (Li-Cor
Biosciences) diluted 1:1 with PBS (OBB-PBS) for 1 h at RT and
washed 3× with 0.1% Tween-20 in PBS. Hydrogels were incubated
with biotinylated goat antihuman EGF detection antibody at a
concentration of 50 ng/mL in OBB-PBS for 2 h at RT with constant
agitation at 30 rpm. The washing steps were repeated and hydrogels
were incubated with streptavidin-HRP diluted 1:40 in OBB-PBS for 20
min at RT with constant agitation at 30 rpm and protected from light.
After washes, hydrogels were incubated with substrate solution
consisting of a 1:1 mixture of Color Reagent A (H2O2) and Color
Reagent B (tetramethylbenzidine) (R&D Systems, DY994) for 20−30
min at RT protected from light. The reaction was stopped with 1 M
H2SO4. Aliquots (20 μL) of supernatant were transferred to a clear
bottom Nunc MaxiSorp 384-well plate (Thermo Scientiﬁc) and
absorbance at 450 nm was measured using a microplate reader
(SpectraMax M2e, Molecular Devices). Absorbance at 540 nm was
subtracted to account for optical imperfections of the plate.
2.5. Quantiﬁcation of Sortase-Mediated Cleavage of
Tethered EGF from Hydrogels. A modiﬁed sandwich ELISA was
used to measure the amount of EGF cleaved from hydrogels in the
presence of sortase A and GGG peptide. GGG-EGF-tethered
hydrogels were soaked in calcium buﬀer for 1 h at 4 °C and incubated
for 48 h at 4 °C with constant agitation in 50 μL/well cleavage
solution containing 20 mM GGG and 200 μM sortase in calcium
buﬀer. Supernatants were collected and frozen. A clear bottom Nunc
MaxiSorp 384-well plate (Thermo Scientiﬁc) was coated with mouse
antihuman EGF capture antibody diluted at the recommended
concentration of 4.0 μg/mL in sterile PBS. The plate was covered
with an adhesive strip, spun at 1500 rpm for 3 min and incubated
overnight at 4 °C with constant agitation. Three washing steps with
100 μL/well 0.1% Tween-20 in PBS were performed at RT using an
automatic plate washer (405 Touch Microplate Washer, BioTek). The
plate was blocked with 100 μL/well OBB-PBS and incubated for 2 to 6
h at RT with constant agitation at 30 rpm. Samples were ﬁrst diluted
with calcium buﬀer containing 1% BSA in 1.5 mL Protein LoBind
tubes (Eppendorf) and then serially diluted in 0.5 mL Protein LoBind
tubes. Standard curves were made by serially diluting GGG-EGF in 1%
BSA in calcium buﬀer. After the washing steps, samples were plated
and the plate was covered with an adhesive strip, spun at 1500 rpm for
3 min and incubated for 2 h at RT with constant agitation. This
process was repeated with the biotinylated goat antihuman EGF
detection antibody diluted at the recommended working concen-
tration of 50 ng/mL in OBB-PBS. The plate was washed, incubated
with streptavidin-HRP diluted 1:40 in OBB-PBS and spun at 1500 rpm
for 3 min protected from light. After 20 min incubation at RT with
constant agitation, the plate was washed and incubated with substrate
solution for 20−30 min at RT protected from light. The reaction was
stopped with 1 M H2SO4 and absorbance at 450 nm was measured.
2.6. Human Cryopreserved Hepatocyte Culture on Hydro-
gels. After a PBS wash and UV-sterilization, hydrogels were soaked in
human hepatocyte seeding medium (hHSM; Williams E medium
supplemented with 5% FBS, 1 μM hydrocortisone, 1% penicillin/
streptomycin (P/S), 4 μg/mL human recombinant insulin, 2 mM
GlutaMAX, 15 mM HEPES (pH 7.4); CM3000) with or without 20
ng/mL hEGF for 1 h. Cryopreserved hepatocytes were quickly thawed
in a 37 °C water bath, transferred into a 50 mL falcon tube with 25 mL
prewarmed Cryopreserved Hepatocyte Recovery Medium (CHRM;
CM7000) and centrifuged at RT at 100g for 8 min. Warm hHSM (1
mL) was added to the cell pellet and cells were gently rocked, counted
(Countess Cell Counter, Invitrogen) and placed on ice. Hepatocytes
were seeded on hydrogels and on collagen I-coated (BioCoat, BD
Biosciences) wells in 96-well angiogenesis plates at a density of 60 000
cells/cm2 (7500 cells/well) in 50 μL/well hHSM. Hepatocytes were
incubated at 37 °C, 95% air, 5% CO2. Twenty-four hours after cell
seeding, medium was switched to serum-free human hepatocyte
maintenance medium (hHMM; Williams E medium supplemented
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with 0.1 μM hydrocortisone, 0.5% P/S, ITS+ (human recombinant
insulin (6.25 μg/mL), human transferrin (6.25 μg/mL), selenous acid
(6.25 ng/mL), bovine serum albumin (1.25 mg/mL), linoleic acid
(5.35 μg/mL)), 2 mM GlutaMAX, 15 mM HEPES (pH 7.4);
CM4000) with or without 20 ng/mL hEGF and cells were incubated
for 24 h.
2.7. Endometrial Biopsy Collection and Isolation. Eutopic
endometrial biopsies were obtained from two premenopausal women
in the proliferative phase of the menstrual cycle, who were undergoing
surgery for benign gynecological diseases. Selective criteria included
that the patients had regular menstrual cycles (26 to 35 days) and were
not using hormonal treatment for at least 3 months prior to surgery. A
standardized questionnaire was used to document all clinical data.
Tissues were collected with the approval of the Partners Human
Research Committee and the Massachusetts Institute of Technology
Committee on the Use of Humans as Experimental Subjects and with
the informed consent of each patient. Endometrial Pipelle biopsies
were dissociated and cells puriﬁed as described by Osteen and co-
workers34 with some modiﬁcations (Supporting Information).
2.8. Endometrial Epithelial Cell Culture on Hydrogels. Before
cell seeding, hydrogels were washed with PBS, UV-sterilized for 15
min and soaked in DMEM/F12/FBS (mixture of Dulbecco’s Modiﬁed
Eagle’s Medium and Ham’s F-12 (Gibco) supplemented with 1%
penicillin/streptomycin and 10% v/v dextran/charcoal treated fetal
bovine serum (Atlanta Biologicals) with or without 20 ng/mL hEGF
for 1 h. Cultured endometrial epithelial cells (EECs) were trypsinized
and seeded on hydrogels and on standard tissue-culture polystyrene
(TCPS) in 96-well angiogenesis plates at a density of 20 000 cells/cm2
(2500 cells/well) in 50 μL/well DMEM/F12/FBS. EECs were
incubated at 37 °C, 95% air, 5% CO2. Twenty-four hours after cell
seeding, medium was switched to serum-free medium DMEM/F12
with or without 20 ng/mL hEGF and cells were incubated for 16 h.
2.9. DNA Synthesis Assay. Click-iT EdU Alexa Fluor 488 kit
(Life Technologies) was used to quantify cells actively synthesizing
DNA. Forty-eight hours after cell seeding, hepatocytes were incubated
in hHMM with 10 μM of 5-ethynyl-2′-deoxyuridine (EdU) in with or
without 20 ng/mL (3.3 nM) hEGF for 24 h at 37 °C, 95% air, 5%
CO2. Similarly, EECs were incubated 40 h post seeding with 10 μM
EdU in DMEM/F12 with or without 20 ng/mL (3.3 nM) hEGF for 24
h. Both cell-types were ﬁxed with 3.7% formaldehyde in PBS for 15
min at RT. Cells were washed twice with 3% BSA in PBS and
permeabilized with 0.5% Triton X-100 in PBS for 20 min at RT. Click-
iT reaction cocktail was prepared as described by the manufacturer and
20 μL per well was added. Cells were incubated for 30 min at RT
protected from light. After cells were washed once with 3% BSA in
PBS and once with PBS, they were incubated with Hoechst 33342
diluted 1:2000 in PBS for 30 min at RT protected from light. Cells
were ﬁnally washed twice with PBS and imaged using a Leica DMI
6000 microscope and Oasis Surveyor software. Images were processed,
and cell nuclei were counted using ImageJ64 software. The percentage
of cells synthesizing DNA was computed as the ratio of cells positively
stained with Alexa Fluor 488 divided by the total number of cells given
by Hoechst counter-staining.
3. RESULTS AND DISCUSSION
We ﬁrst evaluated the ability of the evolved triple mutant of the
sortase A to tether the solution-phase GGG-EGF nucleophile to
LPRTG substrate motifs that were covalently incorporated in
PEG hydrogels (LPRTG-gel). Compared to the wild-type
sortase, this mutant displays a 3-fold improvement in turnover
(kcat = 4.8 ± 0.6 s
−1) and a 14-fold improvement in the aﬃnity
for the LPXTG substrate (Km LPXTG = 0.56 ± 0.007 mM),
resulting in a 43-fold increase of catalytic eﬃciency (kcat/
Km LPXTG = 8600 ± 1500 M
−1 s−1), although the aﬃnity for the
N-terminal GGG substrate is less favorable.32 These enhanced
properties were predicted to allow eﬃcient catalysis at the
relatively low LPXTG substrate concentrations in the hydro-
gels.
Sortase-mediated ligation was characterized by three
complementary methods: measurement of the consumption
of the GGG-EGF nucleophile from the reaction solution,
measurement of the consumption of the LPRTG-gel substrate,
and measurement of GGG-EGF released from the hydrogel
after sortase-mediated cleavage of tethered EGF from the
hydrogel. We also used a direct on-gel ELISA approach to
assess EGF accessibility. The results of these experiments were
used to deﬁne suitable tethering conditions to create synthetic
ECM for modulation of epithelial cell DNA synthesis.
3.1. The Amount of GGG-EGF Consumed from
Solution in the Presence of Sortase Depends on
LPRTG-Gel Concentration. We ﬁrst measured the disappear-
ance of the GGG-EGF nucleophile from the supernatants of
PEG hydrogels fabricated with systematically varied LPRTG-gel
concentrations (0, 20, 50, 100, or 250 μM, corresponding to 0,
200, 500, 1000, and 2500 total pmol LPRTG per hydrogel) and
then exposed to coupling solutions containing 15 μM (750
Figure 1. Amount of GGG-EGF peptide nucleophile remaining in solution as a function of total LPRTG concentration in hydrogel. GGG-EGF is
quantiﬁed by sandwich ELISA before and after sortase-mediated ligation of GGG-EGF to preformed hydrogels containing LPRTG, using nucleophile
concentrations of 2 μM (A) or 20 μM (B). The amount of GGG-EGF remaining in solution after sortase-mediated ligation decreases with increasing
LPRTG concentration in hydrogel. Error bars represent standard error of the mean (n = 2).
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pmol) sortase and GGG-EGF at concentrations of either 2 μM
(100 pmol total peptide) or 20 μM (1000 pmol total peptide)
to tether EGF via Scheme 1. The amount of GGG-EGF present
in the reaction supernatant was measured by sandwich ELISA
at the start and end of the reaction.
For control hydrogels (i.e., LPRTG-gel = 0 μM), GGG-EGF
diﬀuses into the hydrogel but does not react even in the
presence of sortase. The observed reduction in GGG-EGF
concentration in the supernatant of control hydrogels due to
this partitioning was 6% for both the 2 and 20 μM GGG-EGF
conditions (Figure 1A,B), a value about half that expected
based on simple dilution due to the volume of liquid in the
hydrogel and consistent with the protein-repulsion properties
of PEG. For both the 2 μM and 20 μM GGG-EGF coupling
concentrations, GGG-EGF depletion from the coupling
solution increased with increasing concentrations of LPRTG-
gel (Figure 1A,B) in a manner consistent with enzyme catalysis
of the reaction. For the 2 μM GGG-EGF coupling condition
(Figure 1A), total LPRTG-gel is always in stoichiometric excess
to total GGG-EGF (200−2500 pmol LPRTG: 100 pmol GGG-
EGF); hence, the incomplete depletion of GGG-EGF substrate
(∼20% at each condition) indicates a kinetic or thermodynamic
limit to coupling under these conditions. Interestingly, for the
20 μM GGG-EGF coupling condition (Figure 1B), the
proportion of GGG-EGF depleted for each LRPTG-gel
concentration is comparable to that in the 2 μM GGG-EGF
case; i.e., within the error of the ELISA, 10 times as much
GGG-EGF is consumed in the 20 μM versus 2 μM GGG-EGF
coupling condition (Figure 1A,B).
This apparent ﬁrst-order dependence of the reaction on
GGG-EGF concentration is consistent with the reported ping-
pong bibi mechanism for sortase A,35 where a thioacyl
intermediate is resolved by the N-terminus of an oligoglycine
nucleophileprovided that there is suﬃcient oligoglycine to
render the competing reaction, hydrolysis,16 relatively unim-
portant. However, the interpretation of the results from this
pilot experiment is inherently limited by the convolution of two
rate processesenzyme kinetics and enzyme/substrate dif-
fusionoccurring simultaneously with a complex reaction
mechanism, which can include not only ligation but also
hydrolysis. Based on size, the diﬀusion coeﬃcients of GGG-
EGF and sortase in water are about 2.5 × 10−6 cm2/s and 1.5 ×
10−6 cm2/s, respectively,36 and diﬀusion of molecules of this
size in the hydrogels would be expected to be hindered by 50−
90%.36−38 We can thus estimate the characteristic diﬀusion
times, τD, for GGG-EGF and sortase in the hydrogel in the
absence of reaction as 0.4−1.8 h and 0.6−3 h, respectively,
using the well-established relationship τD ∼ L2/4DA‑hydrogel
where L is the thickness of the hydrogel (0.8 mm) and
DA‑hydrogel is the eﬀective diﬀusion coeﬃcient for either GGG-
EGF or sortase in the hydrogel. These characteristic diﬀusion
times represent a lower boundary, as interactions with the
LPRTG-gel substrate would be expected to retard diﬀusion and
create gradients in reaction rate during the 1 h incubation. In
summary, this pilot experiment provides compelling evidence
that sortase is capable of tethering relatively large peptides (∼6
kDa) to PEG hydrogels, motivating further characterization of
the reaction process.
3.2. LPRTG Cleavage Product Is Released from the
Hydrogel in the Presence of GGG-EGF and Sortase. In
order to elucidate how many LPRTG molecules were eﬀectively
processed by sortase, 4% of the LPRTG peptides incorporated
into the hydrogels were labeled with ﬂuorescein (LPRTG-fam).
When the sortase enzyme cleaves the peptide bond between
the threonine and the glycine of the LPRTG-fam motif,
ﬂuorescein is released, thus resulting in a decrease of
ﬂuorescence associated with the hydrogel. Fluorescence
intensities after washing for hydrogels before and after
incubation for 1 h with either 2 μM or 20 μM GGG-EGF in
the presence or absence of 15 μM sortase are shown in
Supporting Information Figure 2. After correction for photo-
bleaching, ﬂuorescence intensities were converted to pmol
LPRTG in hydrogel (see Experimental Section), and the
amount of reacted LPRTG was calculated as the diﬀerence
between the values before and after the sortase reaction. As
shown in Figure 2, LPRTG consumption increased with
increasing initial amount of LPRTG in the hydrogels and was
greater for the 20 μM GGG-EGF than the 2 μM GGG-EGF
condition. This pattern is qualitatively consistent with the
trends seen for consumption of GGG-EGF (Figure 1). This
conﬁrms that the triple mutant sortase is capable of recognizing
the LPRTG motif when it is incorporated in PEG hydrogels;
i.e., sortase can cleave the peptide bond between the threonine
and the glycine in order to release the ﬂuorescein from the
hydrogel.
Interestingly, whereas the amount of GGG-EGF consumed
from the supernatant in the 20 μM condition was 10-fold
higher than the amount consumed in the 2 μM condition, the
amount of reacted LPRTG at the 20 μM GGG-EGF condition
was only about 2-fold higher than the reacted LPRTG at the 2
μM condition (Figure 2). We speculate that this discrepancy
arises from a diﬀerence in the relative rates of hydrolysis and
transpeptidation for the diﬀerent GGG-EGF concentrations.
Considering the greatest LPRTG concentration as a represen-
tative case, the number of moles of GGG-EGF consumed (20
pmol and 230 pmol for the 2 μM and 20 μM concentrations,
respectively) is substantially lower than the amount of reacted
LPRTG (140 pmol and 310 pmol for the 2 μM and 20 μM
GGG-EGF concentrations, respectively), and the ratio of
reacted LPRTG:GGG-EGF consumed is much higher for the
lower GGG-EGF concentration. Because the sortase and
LPRTG concentrations compared here are identical and only
the GGG-EGF nucleophile concentration changes, this
observation is consistent with nucleophile starvation at the
Figure 2. Amount of reacted LPRTG as a function of total initial
LPRTG amount in hydrogel. After correction for photobleaching,
ﬂuorescence intensities were converted to pmol LPRTG in the
hydrogel and the amount of reacted LPRTG was calculated as the
diﬀerence between the values before and after sortase-mediated
ligation. Error bars represent standard error of the mean (n = 2).
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lower GGG-EGF concentration leading to proportionately
greater hydrolysis compared to ligation. This interpretation is
plausible as the Km,GGG value is in the millimolar range, and
thus the reaction would be expected to be in a regime that
depends on the GGG-EGF concentration.
3.3. Speciﬁc Tethering of GGG-EGF Increases with
LPRTG Concentration in Hydrogels and GGG-EGF
Concentration in Solution. A noteworthy aspect of
sortase-mediated ligation is that the product formed contains
an LPRTGGG sequence that becomes itself a potential
substrate if a GGG-containing nucleophile is available. During
ligation of GGG-EGF to the hydrogel through the LPRTG
motif covalently incorporated into the hydrogel, this secondary
reaction is minimized by the presence of a substantial
stoichiometric excess of LPRTG substrate compared to GGG-
EGF. However, this feature can also be exploited to cleave EGF
from the hydrogel following ligation, by adding a high
concentration (20 mM) of the simple nucleophile GGG, thus
driving the reaction toward replacement of EGF by GGG and
freeing EGF to the solution phase. Subsequent measurement of
EGF in solution via ELISA allows the amount of ligated (vs
nonspeciﬁcally associated) EGF to be ascertained.
In order to establish reaction conditions that would lead to
complete cleavage of the tethered molecules, we used cleavage
of LPRTG-fam as a surrogate measure for reaction progress. As
noted above, sortase-mediated reactions occurring in the
hydrogel require diﬀusion of the enzyme and substrate into
the hydrogel, a process that likely requires several hours longer
than the 1 h reaction time used for ligation. After the initial
ligation reaction with 2 or 20 μM GGG-EGF, hydrogels
containing 0, 20, 50, 100, or 250 μM of total LPRTG-
containing peptide at a ratio of 4% LPRTG-fam and 96%
LPRTG were incubated with 20 mM GGG and 200 μM sortase
for 48 h at 4 °C. Fluorescence was measured as previously
described. After this cleavage step (i.e., cleavage of previously
tethered GGG-EGF plus LPRTG and LPRTG-fam), the
percentage of residual ﬂuorescence dropped to a similar level
of 9−12% of initial ﬂuorescence for all LPRTG concentrations
and for both GGG-EGF concentrations (Supporting Informa-
tion Figure 3). Residual ﬂuorescence is likely caused by
adsorption of ﬂuorescein to the plastic of the plate or to the
hydrogel, or less likely, by inaccessibility of certain LPRTG-fam
molecules to cleavage. The relatively similar low level of
residual ﬂuorescence observed for all the conditions suggests
that previously tethered GGG-EGF was released completely.
Hydrogel supernatants were collected after all reaction steps,
including washes following sortase-mediated ligation and after
hydrogel cleavage, in order to quantify GGG-EGF with
sandwich ELISA. Figure 3 shows the amount of released
GGG-EGF as a function of LPRTG concentration for sortase-
mediated ligation at 2 and 20 μM GGG-EGF respectively. For
both concentrations, the amount of GGG-EGF released during
washes after tethering is low, constant, and proportional to the
initial concentration of GGG-EGF used (Figure 3). Cleaved
Figure 3. Amount of GGG-EGF released in solution as a function of total LPRTG concentration in hydrogel. GGG-EGF is quantiﬁed by sandwich
ELISA after hydrogel washes and sortase-mediated hydrogel cleavage following tethering of GGG-EGF at either 2 μM (A) or 20 μM (B). The
amount of GGG-EGF released in solution after sortase-mediated cleavage increases with increasing LPRTG concentration in hydrogel. Error bars
represent standard error of the mean (n = 2).
Figure 4. Nucleophile mass balance for sortase-mediated ligation of GGG-EGF to LPRTG-containing hydrogels as a function of LPRTG
concentration in the hydrogel and for GGG-EGF concentrations of either 2 μM (A) or 20 μM (B). The amount of GGG-EGF present in initial
tethering solution and in hydrogel supernatant after washes and after cleavage was quantiﬁed by sandwich ELISA. Error bars represent standard error
of the mean (n = 2).
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EGF increased with LPRTG concentration in the hydrogels and
is also proportional to the GGG-EGF in the initial tethering
solution, a trend consistent with previous experiments. The
sum of the amounts of GGG-EGF left in solution after ligation,
extracted in washes, and released by cleavage should be equal to
the amount of GGG-EGF present in the original coupling
solution. Indeed, this is the case for most of the conditions, as
shown in Figure 4. For sortase-mediated ligation at 2 μM
GGG-EGF, a maximal amount of 19 pmol of GGG-EGF was
found to be cleaved from hydrogels (Figure 3A), equivalent to
the 20 pmol obtained from quantiﬁcation of depletion from the
original reaction solution with a sandwich ELISA after the
reaction (Figure 1A). Further, this suggests that at this
nucleophile concentration, all the consumed GGG-EGF is
tethered to the hydrogel with imperceptible nonspeciﬁc
binding. At 20 μM GGG-EGF initial concentration, a maximal
amount of ∼160 pmol released GGG-EGF was detected, for
hydrogels with 250 μM LPRTG-gel (Figure 3B). This means
that from the estimated 230 pmol GGG-EGF that disappeared
from the initial ligation reaction supernatant (Figure 1B), 160
pmol GGG-EGF was tethered to the hydrogel. Further, ∼11
pmol was recovered from washes (i.e, presumably partitioned
into the aqueous phase of the hydrogel without binding),
leaving a balance of 59 pmol that is presumably adsorbed to the
hydrogel through noncovalent binding mechanisms (Figure
4B). Noncovalent binding, as estimated by the gap between the
sum of the recovered material and that in original ligation
solution, seems to be higher and more uniform relative to the
LPRTG-gel concentration for the 20 μM GGG-EGF condition
(Figure 4B).
3.4. Direct ELISA Reveals Nonlinear Dependence of
Surface-Tethered EGF on Substrate Concentration. The
results of ELISA analysis on the reaction solutions (Figure 1)
and the cleavage products (Figures 3 and 4) provide strong
evidence for covalent sortase-mediated ligation of GGG-EGF to
PEG hydrogels bearing the LPRTG motif, and suggest that the
total amount of EGF tethered to the hydrogel is approximately
proportional to the GGG-EGF concentration in the ligation
solution. As the objective of tethering EGF to the hydrogels is
to stimulate the EGF receptor of cells adhering to the hydrogel
on a sustained basis, thus inﬂuencing downstream phenotypic
responses, we further characterized the EGF tethered to the
hydrogel using a direct ELISA approach to quantify the relative
amounts of accessible EGF tethered under the diﬀerent
substrate conditions. Direct ELISA was conducted by
incubating hydrogels with an anti-EGF antibody for 2 h, and
thus it is expected that antibody binding would be restricted to
near the surface of the hydrogels due to the slow diﬀusion of
large proteins in the hydrogels. In this analysis, hydrogels
incubated with GGG-EGF in the absence of sortase were
included as a control for nonspeciﬁc binding.
The relative amounts of EGF detected by direct ELISA, as a
function of initial LPRTG-gel concentration, GGG-EGF
concentration in the ligation solution, and the presence or
absence of sortase, are shown in Figure 5A as the net signal
after subtraction of background. In agreement with the analysis
presented in Figure 4, nonspeciﬁc interaction of GGG-EGF
with the hydrogel is undetectable at the 2 μM GGG-EGF
concentration, but is signiﬁcant at the 20 μM GGG-EGF
concentration, as evidenced by the detectable signal for
hydrogels incubated with GGG-EGF in the absence of sortase,
the lack of clear dependence of this signal on LPRTG-gel
concentration, and the signiﬁcant increase in the signal for
hydrogels incubated with 20 μM compared to 2 μM GGG-EGF
(Figure 5A). Interestingly, ELISA-detectable EGF increases
with addition of sortase even in the absence of LPRTG-gel (i.e.,
comparison of the points along the vertical axis for LPRTG-gel
= 0 μM in Figure 5A). The magnitude of this increase is
comparable for the 2 μM and 20 μM GGG-EGF conditions. A
plausible explanation is that sortase adsorbs nonspeciﬁcally to
the hydrogels and acts as an aﬃnity capture molecule for GGG-
EGF.
In order to compare the relative amounts of EGF tethered to
hydrogels via sortase-mediated ligation at diﬀerent LPRTG-gel
concentrations for the 2 and 20 μM GGG-EGF tethering
concentrations, the signal associated with incubation in the
absence of sortase was subtracted from the total signal for each
LPRTG-gel concentration for the 2 μM and 20 μM GGG-EGF
cases to normalize the data for nonspeciﬁc association of GGG-
EGF with the hydrogels. The resulting values are plotted in
Figure 5B as a function of LPRTG-gel concentration initially
present in the hydrogel. This plot shows that the net ELISA
signal above background (including nonspeciﬁc adsorption) is
roughly comparable at low (<50 μM) LPRTG-gel concen-
trations for both the 2 μM and 20 μM GGG-EGF substrate
conditions and at high (>50 μM) LPRTG-gel concentrations,
Figure 5. Detection of GGG-EGF on hydrogels as a function of total LPRTG concentration in hydrogel after sortase-mediated ligation of 2 or 20 μM
GGG-EGF. (A) GGG-EGF nonspeciﬁc binding was tested after incubation of the hydrogels with 2 or 20 μM GGG-EGF in the absence of sortase.
(B) Measurements performed without sortase were subtracted from the ones performed in the presence of the enzyme. Error bars represent
standard error of the mean (n = 2).
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the net ELISA signal is about 2-fold greater for the 20 μM
GGG-EGF than that for the 2 μM GGG-EGF condition. The
diﬀerence in this result and the data in Figure 4, where
measurement of cleaved EGF indicates a 10-fold greater
amount of tethered EGF for the higher substrate concentration,
can be interpreted in the context of the complex parallel rate
processes occurring during the ligation reaction and during the
direct ELISA. During reaction, both the substrate GGG-EGF
and the sortase enzyme diﬀuse into the hydrogel, and the
ligation reaction competes with a hydrolysis reaction in a
manner such that hydrolysis is more prominent at very low
GGG-EGF concentrations. Thus, it is likely that the ratio of
tethered EGF for the two diﬀerent substrate concentrations
changes with distance from the surface of the hydrogel, such
that the ratio of [tethered EGF, 20 μM] to [tethered EGF, 2
μM] increases away from the surface, due to the increase in
prominence of hydrolysis in the 2 μM case.
3.5. DNA Synthesis of Primary Human Hepatocytes
and Endometrial Epithelial Cells Is Enhanced by
Tethered EGF. The central objective of tethering EGF to
PEG hydrogels is to present EGF in a mode that engages and
activates the EGF receptor on the basal surface of adherent cells
in a sustained fashion, and does so in the context of an
environment that mimics key adhesion and mechanical features
of extracellular matrix. Epithelial cells polarize EGFR and
EGFR ligands to the basolateral surface, and disruption of this
polarization is associated with disease states.39 Some ligands for
EGFR, such as amphiregulin, are strongly matrix binding and
may act as pseudotethered ligands, hence presentation of EGF
tethered to PEG hydrogels may mimic a mode of natural
stimulation that is deﬁcient in synthetic matrix. We thus
focused on assessing the DNA synthesis response of primary
epithelial cells to tethered EGF as proof-of-principle for the
activity of tethered EGF.
Motivated in part by several studies showing the phenotypic
eﬀects of soluble versus tethered EGF on primary hepato-
cytes,40−42 we examined the DNA synthesis response of
primary human hepatocytes as a metric of tethered EGF
activity. We also investigated the DNA synthesis response of
primary human endometrial epithelial cells, which express
EGFR and respond to EGF stimulation.43 Expansion and
diﬀerentiation of primary human endometrial epithelial cells in
culture is of great interest for study of endometrial biology and
disease. Primary human hepatocytes and primary human
endometrial epithelial cells are also representative of epithelial
cells that are responsive to EGF but relatively refractory toward
in vitro proliferation.
For these proof of principle experiments, we aimed to choose
an EGF concentration in a regime that would be expected to
maximally stimulate DNA synthesis, as human hepatocytes and
endometrial epithelial cells exhibit relatively low rates of DNA
synthesis and growth in vitro compared to cell lines and other
more highly proliferative primary cell types such as
mesenchymal stem cells and keratinocytes. The anticipated
low rates of DNA synthesis under optimal conditions is further
compounded by the potential for the PEG adhesion environ-
ment to further diminish the DNA synthesis response capacity
of EGF-stimulated cells: even cells that proliferate robustly in
response to EGF culture can exhibit diminished proliferation
behaviors when the adhesion context is altered by the presence
of relatively poorly adsorptive PEG chains. For example, in the
challenging application of PDMS surface modiﬁcation with
PEG-tethered EGF for creation of a conﬂuent corneal epithelial
cell monolayer for a biohybrid cornea replacement, tethered
EGF improved cell coverage but the PEG chains impeded
complete, homogeneous monolayer formation.44 We have also
observed that DNA synthesis by primary rat hepatocytes
cultured on glass substrates with PEG-tethered EGF is
diminished when the PEG brush inhibits attachment of
adhesion proteins40 and that tethered EGF improves, but
does not completely rescue, colony formation by primary
human bone marrow stromal cells cultured on PEG-tethered
minimal adhesion peptides compared to untreated glass.45
Given that hydrogels tethered in the presence of 2 μM GGG-
EGF exhibited undetectable (<0.5 pmol) noncovalently bound
EGF and presented abundant surface-accessible EGF (Figure
4A), we used a tethering concentration of 2 μM GGG-EGF
with hydrogels containing 250 μM LPRTG-gel. This concen-
tration ensures that observed eﬀects were due to tethered EGF
and not to noncovalently bound EGF leaching oﬀ the hydrogel.
Further, based on our previous estimates of tethered ligand
density required to stimulate maximal rates of DNA synthesis in
hepatocytes,40 the ligand density in such hydrogels was
anticipated to be suﬃcient to stimulate maximal EGFR
signaling on these epithelial cells. Speciﬁcally, at bulk
concentrations of 250 μM, the LPRTG motif is spaced 19
nm apart on average, yielding an approximate surface density of
about 2500 LPRTG/ μm2. EGF is tethered to yield a ﬁnal
average bulk concentration of 2 μM (20 pmol for 10 μL
hydrogel, data from Figure 1), resulting in an average spacing
between EGF of about 95 nm and average of ∼100 EGF/ μm2.
However, the surface appears to be somewhat enriched for
tethered EGF than the bulk, thus we can estimate that cells
spread to a typical size of 1000 μm2 are exposed to a lower limit
of 100 000 and an upper limit of 2 500 000 molecules of EGF
(the latter presumed all surface LPRTG are modiﬁed by EGF);
i.e., comparable to or in excess of the number of cell surface
receptors.
During the hydrogel fabrication process, hydrogels were
functionalized with a branched peptide containing the PHSRN
and RGD sequences derived from the 9th and 10th type III
repeats in ﬁbronectin. The canonical RGD motif from the 10th
domain interacts primarily with αv integrins and induces
mesenchymal-like behavior in epithelial cells, while inclusion of
the 9th domain PHSRN synergy site fosters interactions
through integrin α5β1 and a more physiological phenotypic
response.46 The synKRGD sequence47 was incorporated into
hydrogels via Michael-type addition through the thiol on the
GGGERCG segment at the time of initial hydrogel synthesis to
give a concentration of 0.5 mM, as we observed in pilot studies
that this concentration was suﬃcient to induce robust
attachment of the epithelial cell types used in this study.
Human primary hepatocytes and endometrial epithelial cells
were cultured on hydrogels containing 0 or 500 μM synKRGD
adhesion peptide. Because the presence of the adhesion peptide
during cross-linking may inﬂuence the structure of the
hydrogels, we substituted peptides with scrambled adhesion
sequences (see Experimental Section) for the active synKRGD
to create the control “0 μM synKRGD” peptide condition. Cells
were either unexposed to EGF, presented with EGF tethered at
2 μM on 250 μM LPRTG-gel hydrogels, or presented with
soluble hEGF at a concentration of 20 ng/mL (3.3 nM). The
KD for EGF binding to EGFR is 0.2−1 nM,40 and the DNA
synthesis response is saturated at soluble EGF values >3 nM.48
DNA synthesis was assessed over a period of 24h, 48 h after
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seeding for hepatocytes and 40 h after seeding for endometrial
epithelial cells.
In the absence of EGF, while only a small number of cells
attached to hydrogels containing 500 μM scrambled adhesion
peptide (“0 μM synKRGD”), cell attachment on 500 μM active
synKRGD hydrogels was comparable to positive controls on
collagen I or TCPS (Figures 6A and C). Tethered EGF had no
eﬀect on hepatocyte attachment, contrary to soluble hEGF,
which slightly enhanced attachment on 500 μM synKRGD
hydrogels compared to unexposed hydrogels, and which yielded
a 1.8 fold increase on collagen I-coated TCP (Figure 6A). In
contrast, tethered EGF was as eﬀective as the soluble form in
fostering endometrial epithelial cell attachment to 0 and 500
μM synKRGD hydrogels (Figure 6C), and soluble EGF
substantially enhanced endometrial epithelial cell attachment
on standard TCPS (Figure 6C).
Additionally, soluble EGF considerably increased DNA
synthesis of primary hepatocytes compared to control cultures
without EGF, from 9 to 21% on 500 μM synKRGD hydrogels
and from 10 to 22% on collagen I-coated TCPS (Figure 6B).
Stimulation of hepatocyte DNA synthesis by tethered EGF
tended to be slightly greater: from 9 to 27% on 500 μM
synKRGD hydrogels (Figure 6B). In previous studies of primary
rat hepatocytes on EGF tethered to glass40 or to self-assembling
peptides hydrogels,41 DNA synthesis rates stimulated by
tethered EGF were comparable to or slightly lower than rates
stimulated by a saturating amount of soluble EGF on hydrogels
or on collagen-coated tissue culture plastic. Human hepatocytes
have previously been reported to exhibit a lower rate of DNA
synthesis than rat hepatocytes when stimulated by soluble
EGF,49 hence, the enhanced DNA synthesis response here for
EGF tethered to synKRGD-modiﬁed hydrogels, compared to
stimulation by soluble EGF of hepatocytes on either synKRGD-
modiﬁed hydrogels or collagen I-coated substrates, may reﬂect
a species diﬀerence. It may also arise from a more favorable
combination of adhesion and EGFR signaling than was
achievable in the glass-tethered or peptide-gel-tethered format.
Primary endometrial epithelial cells also responded to soluble
EGF stimulation by increasing DNA synthesis, from 6 to 12%
on 500 μM synKRGD hydrogels and from 6 to 15% on TCPS
(Figure 6D). The eﬀect of tethered EGF was comparable to
that of soluble EGF in these cells, increasing DNA synthesis
from 6 to 14% compared to control hydrogels (Figure 6D).
These results provide encouraging evidence that EGF
tethered to functionalized PEG hydrogels via sortase-mediated
ligation stimulates biologically relevant responses in primary
human epithelial cells. This study thus provides a foundation
for future analysis of more detailed phenotypic responses.
4. CONCLUSIONS
In conclusion, we report sortase-mediated ligation of human
EGF to preformed PEG hydrogels. This enzymatic approach is
not only simple and relatively inexpensive, but it also displays
high speciﬁcity and modularity, and may be applied to a variety
of PEG hydrogels including those cross-linked in situ in the
presence of cells. A compendium of analytical approaches were
used to show that the amount of grafted growth factor was
readily controlled by the amount of LPRTG substrate
incorporated in hydrogels and the amount of GGG-EGF
present in solution. While the sortase enzyme was capable of
recognizing and processing LPRTG peptides that were
incorporated in the hydrogels through Michael-type addition,
this method represents a useful tool for speciﬁc modiﬁcation of
any type of hydrogel containing the appropriate substrate. The
Figure 6. Cell attachment and DNA synthesis of primary human hepatocytes (A, B) and endometrial epithelial cells (C, D). Cells were seeded on
hydrogels containing 0 or 500 μM synKRGD and 250 μM LPRTG and on standard culture substrates. After 48 h (A, B) or 40 h in culture (C, D),
cells were incubated with 10 μM EdU for 24 h. Tethered EGF stimulated DNA synthesis compared to unmodiﬁed hydrogels or soluble hEGF. Error
bars represent standard error of the mean (n = 3).
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results of this study underscore the challenges in interpreting
reaction data for preformed hydrogels, as the combination of
kinetic and diﬀusion phenomena working in concert during the
ligation process may create gradients of enzyme and substrate
in the hydrogels; indeed, here, the growth factor appeared to be
somewhat enriched at the surface of the hydrogels. This study
also underscores the challenges in minimizing noncovalent
binding during such tethering processes, as even with the well-
established antifouling properties of the PEG polymer as well as
enzymatic speciﬁcity, signiﬁcant nonspeciﬁc binding appeared
to occur for high GGG-EGF coupling concentration. One of
the more novel aspects of the study is the exploitation of
sortase as a cleavage enzyme. Eﬃcient and near complete
release of tethered EGF from the hydrogels through sortase-
catalyzed reaction of the LPRTG-containing tether with soluble
GGG allows near absolute quantiﬁcation of the previous
tethered protein through well-established solution phase
techniques. Finally, biological activity of the tethered EGF
was conﬁrmed by the phenotypic response of human primary
epithelial cells. The well-studied hepatocyte cell system showed
a more robust enhancement to tethered EGF (compared to
soluble EGF) than had been observed in previously published
studies, while preliminary experiments with endometrial
epithelial cells constituted a ﬁrst example of endometrial
epithelial cell culture in the presence of a tethered growth
factor. This demonstration of sortase-mediated ligation of
bioactive molecules to hydrogels will likely contribute to the
development of improved culture systems for in vitro models,
by expanding the repertoire of bioactive molecules that can be
covalently attached to PEG to include large peptides and
proteins.
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